Katrina Megget[email protected]ConferenceQuestions, dilemmas abound in fast-moving world of trauma imagingTime is of the essence when it comes to polytrauma, yet numerous questions arise about how and who should be scanned and for which conditions. For a trauma team, making the right imaging decisions for patients with severe injuries can be complex and a matter of life and death. Trauma specialists shared their experiences at today's session at ECR 2018.March 3, 2018ConferenceNecessity of gadolinium contrast comes under scrutinyGadolinium-enhanced MRI scans have been the gold standard in suspected cases of vestibular schwannoma and multiple sclerosis (MS), but given the growing evidence of deposits left in the brain, debate has ensued about how to image wisely. Is it always necessary to use gadolinium contrast agents? Regarding vestibular schwannoma and MS, today's Pros and Cons Session will explore this question.March 1, 2018ConferenceSafety issues linger over gadolinium-based contrast agentsConclusive research into the safety of gadolinium-based contrast agents could take about a decade to emerge because of the huge difficulties of obtaining enough valuable and objective data. In the meantime, radiologists will be dependent on newly released guidelines from the world's health watchdogs and other reports, ECR 2018 delegates will learn at today's Special Focus Session.February 27, 2018ConferenceTo be or not to be alarmed over gadolinium contrast? That is the questionThe medical imaging community should be neither alarmed nor develop a gadolinium phobia while waiting for guidance from regulators over controversial gadolinium contrast agents. This is the opinion of Dr. Howard Rowley from the University of Wisconsin in the U.S. and president of the American Society of Neuroradiology.March 2, 2017ConferenceCost-effectiveness, implementation still hinder lung cancer screeningThe public desire for lung cancer screening and the ability of the medical profession to implement it are currently at odds, despite recent findings that suggest screening via low-dose CT can reduce mortality. The problem is lung cancer screening remains controversial and is not as straightforward as most people think, according to Dr. Stefan Diederich, PhD.March 1, 2017Page 1 of 1Top StoriesMolecular ImagingEANM puts focus on theranostics at 2024 annual meetingThe EANM has highlighted the central themes of its annual congress to be held in Hamburg from 19 to 23 October, emphasizing a plenary session called “The Age of Theranostics.”Artificial IntelligenceGPT-4V flops on RSNA ‘Case of the Day’ questionsIndustry NewsPhilips reveals greenhouse gas emissions successClinical NewsSiemens co-launches €27 million stroke care programSponsor ContentFree Webinar: Leveraging Enterprise Imaging for Radiologist Well-Being